{
    "id": "47163530",
    "text": "5F-APINACA (also known as 5F-AKB-48 or 5F-AKB48) is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. Structurally it closely resembles cannabinoid compounds from patent WO 2003/035005 but with a 5-fluoropentyl chain on the indazole 1-position, and 5F-APINACA falls within the claims of this patent, as despite not being disclosed as an example, it is very similar to the corresponding pentanenitrile and 4-chlorobutyl compounds which are claimed as examples 3 and 4.WO 2003/035005 5F-APINACA was first identified in South Korea. It is expected to be a potent agonist of the CB1 receptor and CB2 receptor. Its metabolism has been described in literature. ==Pharmacology== 5F-APINACA acts as a full agonist with a binding affinity of 1.94 nM at CB1 and 0.266 nM at CB2 cannabinoid receptors. ==Legality== In the United States, 5F-APINACA is a Schedule I controlled substance. 5F-APINACA is an Anlage II controlled drug in Germany since July 2013. As of October 2015, 5F-APINACA is a controlled substance in China. 5F-APINACA is banned in the Czech Republic. ==See also== * 5F-ADB * 5F-AMB * AB-FUBINACA * AB-CHFUPYCA * AB-PINACA * ADB-CHMINACA * ADB- FUBINACA * ADB-PINACA * ADBICA * APICA * APINACA * FUB-APINACA * MDMB-CHMICA * PX-3 ==References== ==External links== * Category:Adamantanes Category:Cannabinoids Category:Designer drugs Category:Organofluorides Category:Indazolecarboxamides ",
    "title": "5F-APINACA"
}